Cargando…

Cluster headache: new targets and options for treatment

Cluster headache is a severe headache disorder with considerable impact on quality of life. The pathophysiology of the disease remains poorly understood. With few specific targets for treatment, current guidelines mainly include off-label treatment with medication. However, new targets for possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Doesborg, Patty, Haan, Joost
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861507/
https://www.ncbi.nlm.nih.gov/pubmed/29623198
http://dx.doi.org/10.12688/f1000research.13380.1
_version_ 1783308109227229184
author Doesborg, Patty
Haan, Joost
author_facet Doesborg, Patty
Haan, Joost
author_sort Doesborg, Patty
collection PubMed
description Cluster headache is a severe headache disorder with considerable impact on quality of life. The pathophysiology of the disease remains poorly understood. With few specific targets for treatment, current guidelines mainly include off-label treatment with medication. However, new targets for possible treatment options are emerging. Calcitonin gene-related peptide (CGRP)-targeted medication could become the first (cluster) headache-specific treatment option. Other exciting new treatment options include invasive and non-invasive neuromodulation techniques. Here, we provide a short overview of new targets and treatment options that are being investigated for cluster headache.
format Online
Article
Text
id pubmed-5861507
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-58615072018-04-04 Cluster headache: new targets and options for treatment Doesborg, Patty Haan, Joost F1000Res Review Cluster headache is a severe headache disorder with considerable impact on quality of life. The pathophysiology of the disease remains poorly understood. With few specific targets for treatment, current guidelines mainly include off-label treatment with medication. However, new targets for possible treatment options are emerging. Calcitonin gene-related peptide (CGRP)-targeted medication could become the first (cluster) headache-specific treatment option. Other exciting new treatment options include invasive and non-invasive neuromodulation techniques. Here, we provide a short overview of new targets and treatment options that are being investigated for cluster headache. F1000 Research Limited 2018-03-20 /pmc/articles/PMC5861507/ /pubmed/29623198 http://dx.doi.org/10.12688/f1000research.13380.1 Text en Copyright: © 2018 Doesborg P and Haan J http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Doesborg, Patty
Haan, Joost
Cluster headache: new targets and options for treatment
title Cluster headache: new targets and options for treatment
title_full Cluster headache: new targets and options for treatment
title_fullStr Cluster headache: new targets and options for treatment
title_full_unstemmed Cluster headache: new targets and options for treatment
title_short Cluster headache: new targets and options for treatment
title_sort cluster headache: new targets and options for treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861507/
https://www.ncbi.nlm.nih.gov/pubmed/29623198
http://dx.doi.org/10.12688/f1000research.13380.1
work_keys_str_mv AT doesborgpatty clusterheadachenewtargetsandoptionsfortreatment
AT haanjoost clusterheadachenewtargetsandoptionsfortreatment